- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.09. | TOI Management, LLC: The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos | 3 | GlobeNewswire (USA) | ||
| 14.08. | Gewinnverfehlung überschattet Umsatzplus: Aktie von The Oncology Institute bricht um 7 % ein | 3 | Investing.com Deutsch | ||
| ONCOLOGY INSTITUTE Aktie jetzt für 0€ handeln | |||||
| 14.08. | The Oncology Institute GAAP EPS of -$0.15 misses by $0.03, revenue of $119.8M beats by $6.63M | 3 | Seeking Alpha | ||
| 14.08. | The Oncology Institute anticipates Q4 adjusted EBITDA positivity as pharmacy revenue grows 41% | 5 | Seeking Alpha | ||
| 13.08. | Earnings Call: The Oncology Institute steigert Umsatz und verbessert Profitabilität im Q2 2025 | - | Investing.com Deutsch | ||
| 13.08. | Oncology Institute, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.08. | The Oncology Institute names Anne McGeorge as new chairman | 1 | Investing.com | ||
| 13.08. | The Oncology Institute ernennt Anne McGeorge zur neuen Aufsichtsratsvorsitzenden | 3 | Investing.com Deutsch | ||
| 13.08. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.08. | The Oncology Institute Announces Changes to Board of Directors | 1 | GlobeNewswire (USA) | ||
| 12.08. | Earnings Outlook For The Oncology Institute | 1 | Benzinga.com | ||
| 23.07. | The Oncology Institute stock initiated with Outperform rating at Noble Capital | 17 | Investing.com | ||
| 16.07. | The Oncology Institute stock initiated with Buy rating at B.Riley | 1 | Investing.com | ||
| 16.07. | B.Riley stuft The Oncology Institute mit "Buy" ein und sieht Kursziel bei 6,00 $ | 1 | Investing.com Deutsch | ||
| 14.07. | The Oncology Institute Names Kristin England as Chief Administrative Officer | 1 | GlobeNewswire (USA) | ||
| 09.07. | The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members | 2 | Insider Monkey | ||
| 30.06. | The Oncology Institute wird exklusiver Anbieter für Nevada Medicaid | 1 | Investing.com Deutsch | ||
| 30.06. | The Oncology Institute to serve as exclusive provider for Nevada Medicaid | 1 | Investing.com | ||
| 30.06. | The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada | 1 | GlobeNewswire (USA) | ||
| 06.06. | The Oncology Institute files for $50M common stock offering | 2 | Seeking Alpha |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,112 | -0,88 % | Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference | ||
| ATOSSA THERAPEUTICS | 0,680 | -0,44 % | Atossa Genetics stock rating reiterated by H.C. Wainwright on FDA meeting plans | ||
| PING AN HEALTHCARE | 2,516 | +1,49 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,260 | -0,76 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| VERU | 3,820 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| CYTOSORBENTS | 0,853 | +5,96 % | CytoSorbents bei H.C. Wainwright: Strategisches Wachstum und regulatorische Herausforderungen | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| VOLITIONRX | 0,631 | 0,00 % | H.C. Wainwright bestätigt Kaufempfehlung für VolitionRX nach Partnerschaft mit Werfen | ||
| EKSO BIONICS | 4,070 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 4,900 | +2,51 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
| BEYOND AIR | 2,260 | 0,00 % | Beyond Air, Inc. - 8-K, Current Report | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,449 | -5,87 % | Novacyt S.A. - Liquidity Agreement Monthly Update and TVR | ||
| AROVELLA THERAPEUTICS | 0,041 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: S&P DJI Announces September 2025 Quarterly Rebalance |
ONCOLOGY INSTITUTE INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,110 (-3,40 %) liegt der Kurs bei 3,125 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONCOLOGY INSTITUTE INC finden Sie auf Wallstreet Online.